EUNICE THEODOR: Open Payments
NPI 1720471147 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 19 payments from 12 companies in 2025. Trend: 2023 $88 · 2024 $399 · 2025 $477
Food & beverage: $477
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $174 |
| Novo Nordisk Inc | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Boston Scientific Corporation | 1 | $43 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: FREESTYLE LIBRE 3, Wegovy, FARXIGA, General - Pain Management, SHINGRIX, Veozah, VRAYLAR, OFEV.
Industry payments across GA — which companies pay providers there.
